Ependymomas usually develop from neuroectodermal organs. Pure ovarian ependymoma is an extremely rare tumor. We report a patient with ovarian ependymoma who died at the age of 28, 9 years after initial surgery and subsequent intensive combination therapy (chemotherapy, irradiation and hyperthermotherapy) for repeated relapses and metastatic tumors. The diagnosis was confirmed by histopathological and immunohistochemical studies. For recurrent and persistent ependymoma, a combination of the treatment modalities described above is suggested to be beneficial in attenuating the rapid progress and spread of this disease.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0301-2115(97)00134-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Erratum to "Ependymoma of the broad ligament mimicking an ovarian surface epithelial tumor" [Radiology Case Reports 16 (2021) 210-214].
Radiol Case Rep
September 2022
Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya 464-8601, Japan.
[This corrects the article DOI: 10.1016/j.radcr.
View Article and Find Full Text PDFOvarian tissue cryopreservation and transplantation in patients with central nervous system tumours.
Hum Reprod
April 2021
Pôle de Gynécologie, Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain, Brussels, Belgium.
Article Synopsis
- A study investigated the risk of cancer cell reseeding in frozen ovarian tissue from 20 patients with CNS tumors, using various detection methods.
- Results showed no signs of malignancy in the cryopreserved ovarian tissue, as assessed by histology, immunohistochemistry, and molecular techniques.
- This research indicates that transplanting frozen ovarian tissue from these patients may be safe, despite prior concerns about potential cancer cell presence.
Ependymoma of the broad ligament mimicking an ovarian surface epithelial tumor.
Radiol Case Rep
January 2021
Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya 464-8601, Japan.
We report a case of ependymoma of the broad ligament occurring in a 21-year-old woman. CT and MRI findings showed a 40-mm-diameter, well-demarcated cystic mass with a lobulated solid component in the right pelvis. The solid component showed heterogeneous intermediate signal intensity on T2-weighted image and prolonged mild contrast enhancement.
View Article and Find Full Text PDFOvarian ependymoma presenting in pregnancy: a case report and literature review.
BMC Pregnancy Childbirth
November 2020
Department of Obstetrics and Gynecology, Second hospital of Hebei medical university, Heping West Road No. 215, Hebei province, 050000, Shijiazhuang City, China.
Background: Ovarian ependymoma is a rare malignancy. Because of the extreme rarity, certain features of the neoplasm, including its clinical behaviour and optimal therapy, are incompletely characterized.
Case Presentation: A 32-year-old pregnant woman at term presented with a left ovarian neoplasm that occurred in the early stage of pregnancy.
Laparoscopic Ovarian Transposition and Ovariopexy for Fertility Preservation in Patients Treated with Pelvic Radiotherapy with or without Chemotherapy.
Facts Views Vis Obgyn
September 2019
University College London Hospital, Women's Health Division, 250 Euston Road, London NW1 2PG, United Kingdom.
Background: Preservation of fertility in cancer patients of reproductive age is a concern for both the patient and the clinician. In this study, we aimed to study the effectiveness of laparoscopic ovarian transposition or ovariopexy in preserving ovarian function in women undergoing pelvic radiotherapy with or without chemotherapy for pelvic tumours.
Methods: The records of patients who underwent laparoscopic ovarian transposition or ovariopexy prior to pelvic radiation therapy between 2002 and 2018 were reviewed retrospectively.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!